<p><b>A</b>) Representative flow cytometry plots indicating number of Hepa1c1c7 cells taking up propidium iodide (PI) when incubated in 1% normal human serum (NHS) and various concentrations of PPADS (blue lines) or 0.9% NaCl (red lines). <b>B</b>) Mean values ± SEM of PPADS mediated reduction of NHS mediated cell lysis from 5 independent studies. Significant differences are shown as capped lines between vehicle control (0.9% NaCl, 0 µM PPADS) and the various concentrations of PPADS (*** p<0.0005, ** p<0.005, * p<0.05).</p
<p>(A) Real-time PCR for PlGF mRNA in serum-deprived PBS-treated (vehicle) or PLC-treated HMVECs at ...
<p>A, mouse bone marrow derived DCs were stimulated with indicated concentrations of PspA for 24h. B...
<p>Hemolytic assays were performed after incubating normal human serum (NHS) with different amounts ...
<p><b>A</b>) Representative phase contrast images of tubes formed in the absence of supplements (neg...
<p>(A) A representative FACS histogram for hepa-1c1c7 cells treated with either NHS or HI-NHS in med...
<p><b>A.</b> HCT116 cells were pre-treated with or without (control) 10 µM cpdA for 16 hours, expose...
<p>Serum complement was activated by zymosan. Note that PNH serum, which contained eculizumab, was l...
<p>SUM-159 cells were treated with PP (1 nM) or DMSO for 96 hours and subjected to an Aldefluor assa...
<div><p>HepG2 cells were exposed to vehicle (DMSO, control) or increasing concentrations of chenodeo...
<p>Comparison of PS exposure on blood cells among Non-D patients, CAPD patients, HD patients and hea...
The complement system is an important defense mechanism against pathogens; however, in certain patho...
<p>(A) FAD level (β-oxidation impairment) measured as optical density (OD) assay in basal condition ...
<p><b>(A)</b> The inhibition of cell viability after CsA treatment. After adding 5 μg/ml CsA for 72 ...
<p>Anti-PPARβ/δ immunostaining in samples of LR (4–5/group) and 9 paraffin-embedded samples of HCC p...
BACKGROUND: Several studies indicate that plasma membrane changes during apoptosis are a general ph...
<p>(A) Real-time PCR for PlGF mRNA in serum-deprived PBS-treated (vehicle) or PLC-treated HMVECs at ...
<p>A, mouse bone marrow derived DCs were stimulated with indicated concentrations of PspA for 24h. B...
<p>Hemolytic assays were performed after incubating normal human serum (NHS) with different amounts ...
<p><b>A</b>) Representative phase contrast images of tubes formed in the absence of supplements (neg...
<p>(A) A representative FACS histogram for hepa-1c1c7 cells treated with either NHS or HI-NHS in med...
<p><b>A.</b> HCT116 cells were pre-treated with or without (control) 10 µM cpdA for 16 hours, expose...
<p>Serum complement was activated by zymosan. Note that PNH serum, which contained eculizumab, was l...
<p>SUM-159 cells were treated with PP (1 nM) or DMSO for 96 hours and subjected to an Aldefluor assa...
<div><p>HepG2 cells were exposed to vehicle (DMSO, control) or increasing concentrations of chenodeo...
<p>Comparison of PS exposure on blood cells among Non-D patients, CAPD patients, HD patients and hea...
The complement system is an important defense mechanism against pathogens; however, in certain patho...
<p>(A) FAD level (β-oxidation impairment) measured as optical density (OD) assay in basal condition ...
<p><b>(A)</b> The inhibition of cell viability after CsA treatment. After adding 5 μg/ml CsA for 72 ...
<p>Anti-PPARβ/δ immunostaining in samples of LR (4–5/group) and 9 paraffin-embedded samples of HCC p...
BACKGROUND: Several studies indicate that plasma membrane changes during apoptosis are a general ph...
<p>(A) Real-time PCR for PlGF mRNA in serum-deprived PBS-treated (vehicle) or PLC-treated HMVECs at ...
<p>A, mouse bone marrow derived DCs were stimulated with indicated concentrations of PspA for 24h. B...
<p>Hemolytic assays were performed after incubating normal human serum (NHS) with different amounts ...